Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Services. Per the activity note to the FY2024 annual report, the company provides promotional services related to medicines.
Subsidiary of Kerdzo Shezghuduli Pasukhismgeblobis Sazogadoeba AMERISOURCEBERGEN 60 INTERNATIONAL B.V. (100.0%)
| Line item | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|
| Net Cash from Operating Activities | 759 | 822 | 0 | +8.3% |
| Net Cash used in Investing Activities | 283 | 140 | 0 | -50.7% |
| Free Cash Flow (OCF − Capex proxy) | 476 | 683 | 0 | +43.4% |
| Net Cash from Financing Activities | 0 | 365 | 0 | |
| Net Change in Cash (before FX) | 476 | 318 | 0 | -33.2% |
| Effect of FX on Cash | 83 | 74 | 0 | -11.8% |
| Net Change in Cash (incl. FX) | 393 | 245 | 0 | -37.7% |
| Cash at Beginning of Year | 1 | 394 | 0 | nmf |
| Cash at End of Year | 394 | 638 | 0 | +62.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).